CLL: Clinical Trials

1 trial for CLL, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 withdrawn. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Withdrawn 1

Follow CLL: new trials by email Literature Review of CLL trials Research Report on CLL

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Rituximab Plus Venetoclax in Combination With Zandelisib in Subjects With CLL
Zandelisib, Rituximab, Venetoclax - CLL
Phase 2WithdrawnMEI Pharma, Inc.2022-11-222023-03-16

Narrower conditions

Leukemia (1)

Broader conditions

Hematologic Diseases (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)

Interventions

ME-401 (1)  ·  Rituximab (1)  ·  venetoclax (1)

Sponsors

MEI Pharma, Inc. (1)

Countries

United States (1)